Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Lexicon Pharmaceuticals Inc., 3 years.
Lexicon Pharmaceuticals Inc.
Director
CAVA Group Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | CAVA Group Inc. | Grant or award | +1,881 | — | — |
| Jun 3, 2026 | Lexicon Pharmaceuticals Inc. | Option exercise | +89,312 | — | — |
| Jun 20, 2025 | CAVA Group Inc. | Grant or award | +1,767 | — | — |
| May 13, 2025 | Lexicon Pharmaceuticals Inc. | Option exercise | +36,810 | — | — |
| Jun 20, 2024 | CAVA Group Inc. | Grant or award | +1,307 | — | — |
| Apr 28, 2024 | Lexicon Pharmaceuticals Inc. | Option exercise | +8,032 | — | — |
| Nov 17, 2023 | CAVA Group Inc. | Open-market purchase | +10,000 | $33.18 | $331,800 |
| Nov 13, 2023 | Lexicon Pharmaceuticals Inc. | Open-market purchase | +200,000 | $1.01 | $202,000 |
| Jun 20, 2023 | CAVA Group Inc. | Grant or award | +5,000 | — | — |
| May 21, 2023 | Lexicon Pharmaceuticals Inc. | Option exercise | +9,302 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.